1-1 of 1
Authors: Wenfeng Chen
Journal Article
Extended RAS Analysis of the Phase III EPIC Trial: Irinotecan + Cetuximab Versus Irinotecan as Second‐Line Treatment for Patients with Metastatic Colorectal Cancer Open Access
The Oncologist, Volume 26, Issue 2, February 2021, Pages e261–e269, https://doi.org/10.1002/onco.13591
Published: 14 December 2020
